KNOWLEDGE AND ADHERENCE TO WARFARIN’S TREATMENT REGIMEN AMONG PATIENTS IN ALSHAAB AND AHMED GASIM HOSPITALS, SUDAN, 2018

Lina Nasr Mahmoud Ahmed
{"title":"KNOWLEDGE AND ADHERENCE TO WARFARIN’S TREATMENT REGIMEN AMONG PATIENTS IN ALSHAAB AND AHMED GASIM HOSPITALS, SUDAN, 2018","authors":"Lina Nasr Mahmoud Ahmed","doi":"10.56242/globalhealth;2022;2;6;1-5","DOIUrl":null,"url":null,"abstract":"OBEJCTIVE: Warfarin is an oral anticoagulant drug that needs continuous clinical and laboratory monitoring due to its narrow therapeutic index and life-threatening complications. This study aims to assess knowledge and adherence of patients to their warfarin treatment regimen and to identify barriers that prevent patients to take their warfarin therapy regularly. METHODS: In this cross-sectional study, a systematic random sample of 307 patients was selected from Alshaab teaching hospital heart section and Ahmed Gasim Hospital. Data was collected by anonymous interview-based questionnaires. RESULTS: Male patients (52.5%) exceeded females (44.8%), the mean age was 48.79. About 57.98% of the studied patients had moderate overall knowledge score, and more than half of them had good adherence levels (62.2%). The study shows that: Forgetting (43.7%) was the main barrier preventing the patients from taking their medication, followed by drug unavailability (36.8%) and high cost (19.5%). There are statistically significant differences between patient’s age/education and their level of knowledge (p=0.008/p=0.011). The correlations between patients’ adherence to warfarin oral anticoagulant and their level of knowledge is statistically insignificant (r=0.647, p=0.739). There are significant association between patients' level of adherence and the time from which the patient starts to take warfarin (p-value= .034). CONCLUSION: The majority of the studied patients had moderate overall knowledge score about Warfarin oral anticoagulant, and more than half of them had good adherence levels. “Forgetting” was the main barrier preventing the patients from taking their medication. DESCRIPTORS: Warfarin, Knowledge, Adherence, Barriers.","PeriodicalId":285800,"journal":{"name":"Brazilian Journal of Global Health","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56242/globalhealth;2022;2;6;1-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

OBEJCTIVE: Warfarin is an oral anticoagulant drug that needs continuous clinical and laboratory monitoring due to its narrow therapeutic index and life-threatening complications. This study aims to assess knowledge and adherence of patients to their warfarin treatment regimen and to identify barriers that prevent patients to take their warfarin therapy regularly. METHODS: In this cross-sectional study, a systematic random sample of 307 patients was selected from Alshaab teaching hospital heart section and Ahmed Gasim Hospital. Data was collected by anonymous interview-based questionnaires. RESULTS: Male patients (52.5%) exceeded females (44.8%), the mean age was 48.79. About 57.98% of the studied patients had moderate overall knowledge score, and more than half of them had good adherence levels (62.2%). The study shows that: Forgetting (43.7%) was the main barrier preventing the patients from taking their medication, followed by drug unavailability (36.8%) and high cost (19.5%). There are statistically significant differences between patient’s age/education and their level of knowledge (p=0.008/p=0.011). The correlations between patients’ adherence to warfarin oral anticoagulant and their level of knowledge is statistically insignificant (r=0.647, p=0.739). There are significant association between patients' level of adherence and the time from which the patient starts to take warfarin (p-value= .034). CONCLUSION: The majority of the studied patients had moderate overall knowledge score about Warfarin oral anticoagulant, and more than half of them had good adherence levels. “Forgetting” was the main barrier preventing the patients from taking their medication. DESCRIPTORS: Warfarin, Knowledge, Adherence, Barriers.
2018年,苏丹alshaab和ahmed gasim医院患者对华法林治疗方案的了解和遵守情况
目的:华法林是一种口服抗凝药物,由于其治疗指标窄,并发症危及生命,需要持续的临床和实验室监测。本研究旨在评估患者对华法林治疗方案的认知和依从性,并确定阻止患者定期服用华法林治疗的障碍。方法:采用横断面研究方法,系统随机抽取来自Alshaab教学医院心脏科和Ahmed Gasim医院的307例患者。数据通过匿名访谈问卷收集。结果:男性患者(52.5%)多于女性患者(44.8%),平均年龄48.79岁。57.98%的患者总体知识得分为中等,超过一半的患者(62.2%)的依从性良好。研究表明:遗忘(43.7%)是患者服药的主要障碍,其次是药物不可用(36.8%)和费用高(19.5%)。患者的年龄/受教育程度及其知识水平差异有统计学意义(p=0.008/p=0.011)。患者华法林口服抗凝药物依从性与其知识水平的相关性无统计学意义(r=0.647, p=0.739)。患者的依从性水平与患者开始服用华法林的时间之间存在显著相关性(p值= 0.034)。结论:大部分患者华法林口服抗凝药物知识总体得分为中等,半数以上患者依从性良好。“遗忘”是阻碍患者服药的主要障碍。描述:华法林,知识,依从性,障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信